PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
160.27%
Net income growth under 50% of CSIQ's 658.53%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
472.13%
D&A growth of 472.13% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
No Data
No Data available this quarter, please select a different quarter.
-167.22%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-1003.75%
Negative yoy working capital usage while CSIQ is 11.68%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-1494.99%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
9267.16%
Inventory growth of 9267.16% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
69.93%
AP growth of 69.93% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
533.59%
Growth well above CSIQ's 11.68%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-217.35%
Negative yoy while CSIQ is 395.55%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-18.99%
Negative yoy CFO while CSIQ is 128.78%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
29.81%
Some CapEx rise while CSIQ is negative at -10.46%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33200.00%
Both yoy lines negative, with CSIQ at -27.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-86.86%
We cut debt repayment yoy while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-91.62%
Negative yoy issuance while CSIQ is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.